Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and ...

Development of novel influenza neuraminidase inhibitors is critical for preparedness against influenza outbreaks. Knowledge of the neuraminidase enzymatic mechanism and transition-state analogue ...

参考资料： Julia Lederhofer et al. Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase. Immunity, 2024 ...

2022 年 5 月 12 日，武汉大学病毒学国家重点实验室周海兵教授、蓝柯教授、吴叔文副教授合作在国际学术期刊 Cell Insight 发表题为 “ Discovery of Oseltamivir-Based Novel PROTACs as Degraders Targeting Neuraminidase to Combat H1N1 Influenza Virus ” ...

Cidara Therapeutics, a US biotech leveraging its Cloudbreak platform for next‑generation antivirals, saw its stock more than ...

This article considers neuraminidase inhibitors, which are active against influenza virus and are crucial to planning for an influenza pandemic from a new influenza virus of any origin, including a ...

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and mortality. Current ...

The effect of neuraminidase inhibitors on household transmission in Japanese patients with influenza A and B infection: a prospective, observational study. Influenza Other Respir Viruses 2019;13: ...

Please use one of the following formats to cite this article in your essay, paper or report: APA Dutta, Sanchari Sinha Dutta. (2023, February 07). Study characterizes mutations in neuraminidase of ...

InDevR Inc. announced product release of the first ever commercial reagent kit designed explicitly for assessment of neuraminidase (NA) in influenza vaccines. The new kit is poised to help improve ...

Influenza vaccines contain the viral surface proteins hemagglutinin and neuraminidase. While up to now, the constantly changing hemagglutinin has been considered the main protective antigen, and ...